AEON Biopharma annual operating expenses
2021
2022
2023
2024
2025
AEON Biopharma Operating Expenses Growth & History (AEON)
AEON Biopharma's operating expenses was $12.8M for fiscal 2025.
View full AEON Biopharma company overviewAEON Biopharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12.8M | −$60.2M | −82.46% |
| 2024 | 2024-12-31 | $73.0M | −$245.5M | −77.08% |
| 2023 | 2023-12-31 | $318.4M | $270.0M | +557.54% |
| 2022 | 2022-12-31 | $48.4M | $46.5M | +2401.57% |
| 2021 | 2021-12-31 | $1.9M | — | — |
AEON Biopharma quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.9M | $1.6M | +36.45% |
| Q1 2026 | 2026-03-31 | $5.9M | $5.5M | +1184.20% |
| Q4 2025 | 2025-12-31 | $5.5M | — | — |
| Q3 2025 | 2025-09-30 | $2.5M | −$1.5M | −37.92% |
| Q2 2025 | 2025-06-30 | $4.3M | −$149.1M | −97.17% |
| Q1 2025 | 2025-03-31 | $462,000 | −$73.7M | −99.38% |
| Q3 2024 | 2024-09-30 | $4.0M | −$60.3M | −93.75% |
| Q2 2024 | 2024-06-30 | $153.5M | — | — |
| Q1 2024 | 2024-03-31 | $74.2M | $61.1M | +468.37% |
| Q3 2023 | 2023-09-30 | $64.3M | $54.4M | +548.50% |
| Q2 2023 · Jul 21 | 2023-07-21 | $2.6M | $2.2M | +514.93% |
| Q2 2023 · Jun 30 | 2023-06-30 | $14.0M | $13.5M | +3170.33% |
| Q1 2023 | 2023-03-31 | $13.0M | $12.7M | +3253.10% |
| Q4 2022 | 2022-12-31 | $37.7M | $36.8M | +4156.27% |
| Q3 2022 | 2022-09-30 | $9.9M | $9.5M | +2098.53% |
| Q2 2022 | 2022-06-30 | $427,204 | $28,761 | +7.22% |
| Q1 2022 | 2022-03-31 | $389,073 | $188,210 | +93.70% |
| Q4 2021 | 2021-12-31 | $885,745 | — | — |
| Q3 2021 | 2021-09-30 | $450,892 | — | — |
| Q2 2021 | 2021-06-30 | $398,443 | — | — |
| Q1 2021 | 2021-03-31 | $200,863 | — | — |
AEON Biopharma operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, AEON Biopharma's operating expenses increased from $1.9M to $12.8M, a change of $10.9M. The latest reported quarter, Q2 2026, shows $5.9M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AEON Biopharma source filings ↗